Patent details
EP1178826
Title:
IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES
Basic Information
- Publication number:
- EP1178826
- PCT Application Number:
- PCT/US/2000/012583
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009304841
- PCT Publication Number:
- WO/2000/067795
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES
- French Title of Invention:
- IMMUNOTHERAPIE DES MANIFESTATIONS MALIGNES DE LYMPHOCYTES B AU MOYEN D'ANTICORPS ANTI-CD22
- German Title of Invention:
- IMMUNTHERAPIE VON B-ZELL-MALIGNOMEN UNTER VERWENDUNG VON ANTIKÖRPERN GEGEN CD22
- SPC Number:
-
Dates
- Filing date:
- 10/05/2000
- Grant date:
- 19/10/2016
- EP Publication Date:
- 19/10/2016
- PCT Publication Date:
- 16/11/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/02/2002
- EP B1 Publication Date:
- 19/10/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/05/2017
- Expiration date:
- 10/05/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/05/2000
-
-
- Name:
- Immunomedics Inc.
- Address:
- 300 American Road, Morris Plains, NJ 07950, United States (US)
Inventor
- Name:
- GOLDENBERG David, M.
- Address:
- United States (US)
Priority
- Priority Number:
- 307816
- Priority Date:
- 10/05/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 39/395;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |